

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of synapse maturation (GO:0090129) | 8.20627229 |
| 2 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 7.79810866 |
| 3 | regulation of synapse maturation (GO:0090128) | 6.99318906 |
| 4 | single strand break repair (GO:0000012) | 6.90612519 |
| 5 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 6.64532874 |
| 6 | L-fucose catabolic process (GO:0042355) | 6.56467427 |
| 7 | fucose catabolic process (GO:0019317) | 6.56467427 |
| 8 | L-fucose metabolic process (GO:0042354) | 6.56467427 |
| 9 | regulation of G0 to G1 transition (GO:0070316) | 6.38231524 |
| 10 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 6.29367834 |
| 11 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 6.28862538 |
| 12 | cell wall macromolecule catabolic process (GO:0016998) | 5.43948865 |
| 13 | layer formation in cerebral cortex (GO:0021819) | 5.35024263 |
| 14 | protein targeting to lysosome (GO:0006622) | 5.25441444 |
| 15 | establishment of protein localization to vacuole (GO:0072666) | 5.25441444 |
| 16 | protein targeting to vacuole (GO:0006623) | 5.25441444 |
| 17 | negative regulation of heart rate (GO:0010459) | 5.18739458 |
| 18 | cell wall macromolecule metabolic process (GO:0044036) | 5.06009335 |
| 19 | regulation of cilium movement (GO:0003352) | 5.02669059 |
| 20 | negative regulation of catenin import into nucleus (GO:0035414) | 5.02029335 |
| 21 | regulation of p38MAPK cascade (GO:1900744) | 4.85720075 |
| 22 | cAMP catabolic process (GO:0006198) | 4.74571849 |
| 23 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.48552314 |
| 24 | regulation of sarcomere organization (GO:0060297) | 4.48255501 |
| 25 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 4.45617810 |
| 26 | activation of MAPKKK activity (GO:0000185) | 4.38778281 |
| 27 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.34899187 |
| 28 | negative regulation of Ras GTPase activity (GO:0034261) | 4.32145032 |
| 29 | regulation of skeletal muscle contraction (GO:0014819) | 4.28318226 |
| 30 | myoblast migration (GO:0051451) | 4.22231538 |
| 31 | cyclic nucleotide catabolic process (GO:0009214) | 4.20723229 |
| 32 | sphingomyelin metabolic process (GO:0006684) | 4.08585045 |
| 33 | TOR signaling (GO:0031929) | 4.03916501 |
| 34 | pericardium development (GO:0060039) | 4.03639507 |
| 35 | regulation of mesoderm development (GO:2000380) | 3.94655316 |
| 36 | protein localization to vacuole (GO:0072665) | 3.94402838 |
| 37 | protein localization to lysosome (GO:0061462) | 3.94402838 |
| 38 | retinal cone cell development (GO:0046549) | 3.93601802 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.91331639 |
| 40 | sterol catabolic process (GO:0016127) | 3.76831438 |
| 41 | cholesterol catabolic process (GO:0006707) | 3.76831438 |
| 42 | peptidyl-lysine dimethylation (GO:0018027) | 3.68213661 |
| 43 | cellular protein catabolic process (GO:0044257) | 3.67306758 |
| 44 | histone H3-K9 methylation (GO:0051567) | 3.59514167 |
| 45 | endoderm formation (GO:0001706) | 3.59141111 |
| 46 | SMAD protein complex assembly (GO:0007183) | 3.59067860 |
| 47 | pancreas development (GO:0031016) | 3.56125702 |
| 48 | regulation of cell communication by electrical coupling (GO:0010649) | 3.53222609 |
| 49 | cellular potassium ion homeostasis (GO:0030007) | 3.48246074 |
| 50 | oxidative demethylation (GO:0070989) | 3.47753116 |
| 51 | central nervous system neuron axonogenesis (GO:0021955) | 3.42316120 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 3.41616032 |
| 53 | regulation of microtubule-based movement (GO:0060632) | 3.40703187 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.40080163 |
| 55 | plasma membrane repair (GO:0001778) | 3.34447099 |
| 56 | regulation of relaxation of muscle (GO:1901077) | 3.31801942 |
| 57 | negative regulation of ERK1 and ERK2 cascade (GO:0070373) | 3.26255983 |
| 58 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25138649 |
| 59 | I-kappaB phosphorylation (GO:0007252) | 3.24959848 |
| 60 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.23405733 |
| 61 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.21354596 |
| 62 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.20055224 |
| 63 | steroid catabolic process (GO:0006706) | 3.17598245 |
| 64 | activation of protein kinase B activity (GO:0032148) | 3.16923949 |
| 65 | S-adenosylmethionine metabolic process (GO:0046500) | 3.16319785 |
| 66 | negative regulation of protein localization to cell surface (GO:2000009) | 3.07979432 |
| 67 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.05354870 |
| 68 | ribonucleoprotein complex disassembly (GO:0032988) | 2.99994021 |
| 69 | fucosylation (GO:0036065) | 2.98300843 |
| 70 | positive regulation of focal adhesion assembly (GO:0051894) | 2.96461664 |
| 71 | positive regulation of cell junction assembly (GO:1901890) | 2.96461664 |
| 72 | histone H3-K9 modification (GO:0061647) | 2.93430722 |
| 73 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.92842959 |
| 74 | glyoxylate metabolic process (GO:0046487) | 2.89414760 |
| 75 | regulation of fibroblast migration (GO:0010762) | 2.87370162 |
| 76 | regulation of action potential (GO:0098900) | 2.84546815 |
| 77 | organ growth (GO:0035265) | 2.80472528 |
| 78 | limb bud formation (GO:0060174) | 2.78052253 |
| 79 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.76033382 |
| 80 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.73176860 |
| 81 | negative regulation of DNA binding (GO:0043392) | 2.72970378 |
| 82 | fucose metabolic process (GO:0006004) | 2.72568477 |
| 83 | DNA deamination (GO:0045006) | 2.66426823 |
| 84 | regulation of germinal center formation (GO:0002634) | 2.66189573 |
| 85 | regulation of membrane repolarization (GO:0060306) | 2.65616866 |
| 86 | prenylation (GO:0097354) | 2.65150954 |
| 87 | protein prenylation (GO:0018342) | 2.65150954 |
| 88 | negative regulation of endothelial cell migration (GO:0010596) | 2.62157643 |
| 89 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.60625403 |
| 90 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.59799010 |
| 91 | regulation of sequestering of triglyceride (GO:0010889) | 2.58439880 |
| 92 | positive regulation of microtubule polymerization (GO:0031116) | 2.58046745 |
| 93 | positive regulation of adherens junction organization (GO:1903393) | 2.57610986 |
| 94 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.56875499 |
| 95 | embryonic foregut morphogenesis (GO:0048617) | 2.56007556 |
| 96 | behavioral response to nicotine (GO:0035095) | 2.55587559 |
| 97 | sequestering of metal ion (GO:0051238) | 2.54746612 |
| 98 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.53824364 |
| 99 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.53223876 |
| 100 | negative regulation of heart growth (GO:0061117) | 2.53223876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 4.10409127 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.86625072 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.69468512 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.68842914 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.65699576 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.59466539 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50887811 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.43702257 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19228993 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15382060 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12683956 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 1.99530578 |
| 13 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.98137486 |
| 14 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.95115546 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91214903 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90378325 |
| 17 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.86736992 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85433510 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.84754716 |
| 20 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81281081 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78766710 |
| 22 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.77707720 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74968456 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74743917 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70525178 |
| 26 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.70421994 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.69826913 |
| 28 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.67747316 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.67747316 |
| 30 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.67212542 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.62756074 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61848191 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61367135 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.60784124 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60094716 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.57633371 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.56362045 |
| 38 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.53747638 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52741160 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50942207 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.49720094 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.49267148 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.48176843 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.47773047 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.47458875 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47198968 |
| 47 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46103311 |
| 48 | TCF4_23295773_ChIP-Seq_U87_Human | 1.45628355 |
| 49 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.43330555 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42815653 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42317187 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42265981 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41963942 |
| 54 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40142260 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39005341 |
| 56 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.38429992 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36300383 |
| 58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35882901 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35378545 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.35254069 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34730277 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34536159 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34536159 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32661933 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27537284 |
| 66 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27166845 |
| 67 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26980466 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25847050 |
| 69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25446583 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25349655 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23951933 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21765956 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20925623 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20592808 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19627549 |
| 76 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.18802746 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18187889 |
| 78 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16973621 |
| 79 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.15140009 |
| 80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14059027 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13308882 |
| 82 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13192687 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12666986 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12666986 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10700450 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10116569 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10057229 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.09477387 |
| 89 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08993280 |
| 90 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08106055 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07239686 |
| 92 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06964447 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06443525 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06386818 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06048596 |
| 96 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05448706 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05077082 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04416340 |
| 99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02898864 |
| 100 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01681331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008789_abnormal_olfactory_epithelium | 5.29590272 |
| 2 | MP0003787_abnormal_imprinting | 5.12030002 |
| 3 | MP0005499_abnormal_olfactory_system | 4.36883917 |
| 4 | MP0005394_taste/olfaction_phenotype | 4.36883917 |
| 5 | MP0009053_abnormal_anal_canal | 4.05131447 |
| 6 | MP0002735_abnormal_chemical_nociception | 4.01473736 |
| 7 | MP0009840_abnormal_foam_cell | 3.66769165 |
| 8 | MP0004885_abnormal_endolymph | 2.74471012 |
| 9 | MP0001440_abnormal_grooming_behavior | 2.44447134 |
| 10 | MP0005367_renal/urinary_system_phenotyp | 2.34963099 |
| 11 | MP0000516_abnormal_urinary_system | 2.34963099 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.19781900 |
| 13 | MP0001299_abnormal_eye_distance/ | 2.07315270 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.00203208 |
| 15 | MP0004924_abnormal_behavior | 1.98717587 |
| 16 | MP0005386_behavior/neurological_phenoty | 1.98717587 |
| 17 | MP0003121_genomic_imprinting | 1.81146785 |
| 18 | MP0003195_calcinosis | 1.78830854 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.70248438 |
| 20 | MP0006292_abnormal_olfactory_placode | 1.65861755 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 1.64137779 |
| 22 | MP0009745_abnormal_behavioral_response | 1.53641535 |
| 23 | MP0000778_abnormal_nervous_system | 1.51469189 |
| 24 | MP0004142_abnormal_muscle_tone | 1.51185005 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.48590529 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.45189095 |
| 27 | MP0000955_abnormal_spinal_cord | 1.44782754 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.43983256 |
| 29 | MP0002102_abnormal_ear_morphology | 1.42340119 |
| 30 | MP0009250_abnormal_appendicular_skeleto | 1.42207021 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 1.41697236 |
| 32 | MP0001485_abnormal_pinna_reflex | 1.37759809 |
| 33 | MP0002272_abnormal_nervous_system | 1.34678369 |
| 34 | MP0009046_muscle_twitch | 1.34152939 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.34052699 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34050434 |
| 37 | MP0005377_hearing/vestibular/ear_phenot | 1.28645605 |
| 38 | MP0003878_abnormal_ear_physiology | 1.28645605 |
| 39 | MP0001188_hyperpigmentation | 1.27317004 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.25570546 |
| 41 | MP0003136_yellow_coat_color | 1.25380744 |
| 42 | MP0004270_analgesia | 1.25364300 |
| 43 | MP0000049_abnormal_middle_ear | 1.24556847 |
| 44 | MP0000534_abnormal_ureter_morphology | 1.24383109 |
| 45 | MP0001486_abnormal_startle_reflex | 1.23911051 |
| 46 | MP0002233_abnormal_nose_morphology | 1.23774348 |
| 47 | MP0005195_abnormal_posterior_eye | 1.20672729 |
| 48 | MP0003786_premature_aging | 1.16134051 |
| 49 | MP0005360_urolithiasis | 1.14083969 |
| 50 | MP0003879_abnormal_hair_cell | 1.13945481 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 1.13819848 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.11931933 |
| 53 | MP0003868_abnormal_feces_composition | 1.10959867 |
| 54 | MP0001764_abnormal_homeostasis | 1.10866972 |
| 55 | MP0003633_abnormal_nervous_system | 1.10574267 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.09474695 |
| 57 | MP0002163_abnormal_gland_morphology | 1.08163683 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.07084452 |
| 59 | MP0005187_abnormal_penis_morphology | 1.06632485 |
| 60 | MP0008058_abnormal_DNA_repair | 1.06242337 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.05439662 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.04206698 |
| 63 | MP0004147_increased_porphyrin_level | 1.04047923 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 1.03320193 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.02761136 |
| 66 | MP0008872_abnormal_physiological_respon | 1.02173340 |
| 67 | MP0002184_abnormal_innervation | 1.01895781 |
| 68 | MP0002067_abnormal_sensory_capabilities | 0.95555598 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95147328 |
| 70 | MP0002229_neurodegeneration | 0.95120379 |
| 71 | MP0009697_abnormal_copulation | 0.92201490 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.86458306 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 0.85546660 |
| 74 | MP0002752_abnormal_somatic_nervous | 0.85334049 |
| 75 | MP0002064_seizures | 0.82179808 |
| 76 | MP0000470_abnormal_stomach_morphology | 0.81303736 |
| 77 | MP0004215_abnormal_myocardial_fiber | 0.80541767 |
| 78 | MP0003631_nervous_system_phenotype | 0.80305266 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 0.78973307 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.78662335 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 0.76248784 |
| 82 | MP0002557_abnormal_social/conspecific_i | 0.75200950 |
| 83 | MP0001970_abnormal_pain_threshold | 0.74971183 |
| 84 | MP0004811_abnormal_neuron_physiology | 0.74562541 |
| 85 | MP0003119_abnormal_digestive_system | 0.74218552 |
| 86 | MP0005451_abnormal_body_composition | 0.74151599 |
| 87 | MP0002882_abnormal_neuron_morphology | 0.73837709 |
| 88 | MP0001968_abnormal_touch/_nociception | 0.73796425 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 0.73792806 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.72999357 |
| 91 | MP0002063_abnormal_learning/memory/cond | 0.72089208 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.71865175 |
| 93 | MP0000749_muscle_degeneration | 0.69329544 |
| 94 | MP0002736_abnormal_nociception_after | 0.68811292 |
| 95 | MP0001293_anophthalmia | 0.68551229 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.68033354 |
| 97 | MP0003252_abnormal_bile_duct | 0.65285681 |
| 98 | MP0008995_early_reproductive_senescence | 0.60526432 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.60415735 |
| 100 | MP0004133_heterotaxia | 0.59984376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperlipoproteinemia (HP:0010980) | 8.20795787 |
| 2 | Hypoalphalipoproteinemia (HP:0003233) | 6.17562494 |
| 3 | Action tremor (HP:0002345) | 4.77901988 |
| 4 | Xanthomatosis (HP:0000991) | 4.22185600 |
| 5 | Congenital, generalized hypertrichosis (HP:0004540) | 3.72965158 |
| 6 | Prolonged neonatal jaundice (HP:0006579) | 3.69335107 |
| 7 | Febrile seizures (HP:0002373) | 3.64642758 |
| 8 | Choroideremia (HP:0001139) | 3.51171078 |
| 9 | Autoamputation (HP:0001218) | 3.41646721 |
| 10 | Short chin (HP:0000331) | 3.40513855 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.29003543 |
| 12 | Subaortic stenosis (HP:0001682) | 3.29003543 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.27649207 |
| 14 | Alveolar cell carcinoma (HP:0006519) | 3.20790766 |
| 15 | Polyphagia (HP:0002591) | 3.17221143 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.09886430 |
| 17 | Athetosis (HP:0002305) | 3.06711476 |
| 18 | Metaphyseal dysplasia (HP:0100255) | 3.06605989 |
| 19 | Small hand (HP:0200055) | 2.97211992 |
| 20 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.97132870 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 2.96112888 |
| 22 | Bulbous nose (HP:0000414) | 2.93513093 |
| 23 | Protuberant abdomen (HP:0001538) | 2.92946021 |
| 24 | Pancreatic fibrosis (HP:0100732) | 2.84830156 |
| 25 | Fibular aplasia (HP:0002990) | 2.74746982 |
| 26 | Thyroiditis (HP:0100646) | 2.67482140 |
| 27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.58135270 |
| 28 | Abnormality of DNA repair (HP:0003254) | 2.52180969 |
| 29 | Congenital stationary night blindness (HP:0007642) | 2.45814256 |
| 30 | Occipital encephalocele (HP:0002085) | 2.44694066 |
| 31 | Short hallux (HP:0010109) | 2.43027269 |
| 32 | Short 1st metacarpal (HP:0010034) | 2.40805691 |
| 33 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.40805691 |
| 34 | Exercise-induced muscle cramps (HP:0003710) | 2.39241456 |
| 35 | Delayed CNS myelination (HP:0002188) | 2.38532496 |
| 36 | Entropion (HP:0000621) | 2.36084188 |
| 37 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.34827465 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.34033554 |
| 39 | Limb dystonia (HP:0002451) | 2.33173367 |
| 40 | Bell-shaped thorax (HP:0001591) | 2.32061349 |
| 41 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.29043528 |
| 42 | Submucous cleft hard palate (HP:0000176) | 2.28127852 |
| 43 | Constricted visual fields (HP:0001133) | 2.27120415 |
| 44 | Renal cortical cysts (HP:0000803) | 2.25764907 |
| 45 | Tented upper lip vermilion (HP:0010804) | 2.22496026 |
| 46 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.20885429 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.19401216 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.19371560 |
| 49 | Myotonia (HP:0002486) | 2.17538449 |
| 50 | Hypoplastic pelvis (HP:0008839) | 2.17205486 |
| 51 | Abnormality of the 1st metacarpal (HP:0010009) | 2.12666783 |
| 52 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.12289256 |
| 53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09674383 |
| 54 | 2-3 toe syndactyly (HP:0004691) | 2.07927903 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.05166162 |
| 56 | Inability to walk (HP:0002540) | 2.03168054 |
| 57 | Intention tremor (HP:0002080) | 2.03140246 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.02988105 |
| 59 | Anhidrosis (HP:0000970) | 2.02064276 |
| 60 | Pancreatic cysts (HP:0001737) | 2.00810275 |
| 61 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.00680681 |
| 62 | Progressive visual loss (HP:0000529) | 1.98963260 |
| 63 | Brittle hair (HP:0002299) | 1.98871493 |
| 64 | Oligodontia (HP:0000677) | 1.95204796 |
| 65 | Asplenia (HP:0001746) | 1.94145522 |
| 66 | Anophthalmia (HP:0000528) | 1.91744396 |
| 67 | Stereotypic behavior (HP:0000733) | 1.91666858 |
| 68 | Nonprogressive disorder (HP:0003680) | 1.88702759 |
| 69 | Microcytic anemia (HP:0001935) | 1.88247043 |
| 70 | Abnormality of homocysteine metabolism (HP:0010919) | 1.87827203 |
| 71 | Homocystinuria (HP:0002156) | 1.87827203 |
| 72 | Genetic anticipation (HP:0003743) | 1.86471124 |
| 73 | Median cleft lip (HP:0000161) | 1.85654660 |
| 74 | Abnormal eating behavior (HP:0100738) | 1.83062408 |
| 75 | Short tibia (HP:0005736) | 1.82675041 |
| 76 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.81681560 |
| 77 | Stenosis of the external auditory canal (HP:0000402) | 1.80473465 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 1.80127162 |
| 79 | Molar tooth sign on MRI (HP:0002419) | 1.80127162 |
| 80 | Septo-optic dysplasia (HP:0100842) | 1.79976961 |
| 81 | Progressive cerebellar ataxia (HP:0002073) | 1.79914992 |
| 82 | Colon cancer (HP:0003003) | 1.79247321 |
| 83 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.78944331 |
| 84 | Pseudobulbar signs (HP:0002200) | 1.75778267 |
| 85 | Mild short stature (HP:0003502) | 1.75680559 |
| 86 | Cupped ear (HP:0000378) | 1.74955139 |
| 87 | Hypoplasia of the uterus (HP:0000013) | 1.73805501 |
| 88 | Medial flaring of the eyebrow (HP:0010747) | 1.72624415 |
| 89 | True hermaphroditism (HP:0010459) | 1.67616957 |
| 90 | Bile duct proliferation (HP:0001408) | 1.65759425 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 1.65759425 |
| 92 | Hip contracture (HP:0003273) | 1.65227133 |
| 93 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.65049055 |
| 94 | Diplopia (HP:0000651) | 1.65044469 |
| 95 | Abnormality of binocular vision (HP:0011514) | 1.65044469 |
| 96 | Thyroid-stimulating hormone excess (HP:0002925) | 1.64865861 |
| 97 | Fatigable weakness (HP:0003473) | 1.62693425 |
| 98 | Abnormality of the neuromuscular junction (HP:0003398) | 1.62693425 |
| 99 | Abnormality of macrophages (HP:0004311) | 1.60065626 |
| 100 | Congenital hepatic fibrosis (HP:0002612) | 1.58461487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.43259871 |
| 2 | NTRK2 | 5.31329474 |
| 3 | BMPR1B | 4.31625554 |
| 4 | TLK1 | 3.09486935 |
| 5 | AKT3 | 3.06850093 |
| 6 | TGFBR1 | 2.27355728 |
| 7 | FRK | 2.22456082 |
| 8 | PINK1 | 2.02325125 |
| 9 | RIPK1 | 10.2624082 |
| 10 | LMTK2 | 1.83698099 |
| 11 | EIF2AK3 | 1.82087383 |
| 12 | MELK | 1.72496820 |
| 13 | STK16 | 1.57857609 |
| 14 | PHKG2 | 1.57405401 |
| 15 | PHKG1 | 1.57405401 |
| 16 | TNIK | 1.49297540 |
| 17 | NUAK1 | 1.48583721 |
| 18 | MUSK | 1.33871218 |
| 19 | TIE1 | 1.14607956 |
| 20 | WNK3 | 1.11437634 |
| 21 | MARK1 | 1.10438530 |
| 22 | STK39 | 1.05655583 |
| 23 | WNK4 | 1.01592301 |
| 24 | GRK1 | 1.00072429 |
| 25 | OXSR1 | 0.89302764 |
| 26 | FLT3 | 0.82643658 |
| 27 | MAPKAPK5 | 0.80685880 |
| 28 | PKN2 | 0.74873888 |
| 29 | NTRK3 | 0.72424483 |
| 30 | CDK8 | 0.67995496 |
| 31 | ADRBK2 | 0.65942825 |
| 32 | EIF2AK2 | 0.63642486 |
| 33 | CCNB1 | 0.62432554 |
| 34 | MAPK13 | 0.61612087 |
| 35 | CASK | 0.61039888 |
| 36 | DMPK | 0.58380076 |
| 37 | CAMK2A | 0.57224961 |
| 38 | TAOK1 | 0.52168191 |
| 39 | PRKCG | 0.52149163 |
| 40 | MARK2 | 0.45760483 |
| 41 | CAMKK2 | 0.44602066 |
| 42 | RPS6KB2 | 0.43529227 |
| 43 | MAPKAPK3 | 0.43181755 |
| 44 | MAP3K5 | 0.42992312 |
| 45 | PTK2B | 0.42724633 |
| 46 | MAP3K7 | 0.42299900 |
| 47 | BRAF | 0.40579019 |
| 48 | TXK | 0.38713196 |
| 49 | SGK2 | 0.38611683 |
| 50 | CSNK1G2 | 0.37041288 |
| 51 | ADRBK1 | 0.36676189 |
| 52 | MAP2K1 | 0.34175958 |
| 53 | EPHA4 | 0.34163603 |
| 54 | INSR | 0.33395503 |
| 55 | PRKCE | 0.31805077 |
| 56 | EIF2AK1 | 0.31644392 |
| 57 | IGF1R | 0.28983622 |
| 58 | PIK3CA | 0.28373878 |
| 59 | KIT | 0.28332544 |
| 60 | PRKG1 | 0.28273388 |
| 61 | SGK1 | 0.26717397 |
| 62 | PIK3CG | 0.25623092 |
| 63 | INSRR | 0.25301748 |
| 64 | DAPK2 | 0.25111570 |
| 65 | CDK3 | 0.25100135 |
| 66 | DYRK3 | 0.24431640 |
| 67 | RPS6KB1 | 0.23941692 |
| 68 | PRKACA | 0.23814294 |
| 69 | CSNK1A1 | 0.23401004 |
| 70 | CAMK2D | 0.23349207 |
| 71 | CHEK2 | 0.23275594 |
| 72 | PRKCQ | 0.22958832 |
| 73 | MAP4K2 | 0.22180610 |
| 74 | PRKACB | 0.22026202 |
| 75 | CDK19 | 0.21506996 |
| 76 | CDK9 | 0.21051720 |
| 77 | NEK2 | 0.19625295 |
| 78 | DYRK2 | 0.19392269 |
| 79 | MAPK7 | 0.18530155 |
| 80 | NME1 | 0.18396464 |
| 81 | MATK | 0.17598767 |
| 82 | CSNK1G3 | 0.16496649 |
| 83 | MAP3K11 | 0.15876504 |
| 84 | SGK223 | 0.15587849 |
| 85 | SGK494 | 0.15587849 |
| 86 | GRK5 | 0.15057636 |
| 87 | IKBKB | 0.14972245 |
| 88 | CSNK1D | 0.14310645 |
| 89 | ERBB3 | 0.13642912 |
| 90 | ABL1 | 0.13428192 |
| 91 | CAMK2B | 0.13400908 |
| 92 | NTRK1 | 0.13323928 |
| 93 | PLK1 | 0.13116711 |
| 94 | MAP3K4 | 0.13065309 |
| 95 | PRKCA | 0.12713324 |
| 96 | RPS6KA3 | 0.12672965 |
| 97 | CSNK1E | 0.12142073 |
| 98 | PLK2 | 0.12067986 |
| 99 | MAPK14 | 0.11706341 |
| 100 | MAPK12 | 0.11610022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.45369372 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.36235558 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.01786696 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65976358 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38762581 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28458941 |
| 7 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.17822308 |
| 8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.11748850 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.06536448 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.06460462 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.04057363 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.03987596 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.92371369 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.84954403 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.83310053 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69789880 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65114854 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63749902 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62999262 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60180444 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60018236 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58048167 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.51379450 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.40431543 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31439619 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30997516 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29807300 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25418935 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24498630 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24284388 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22288902 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20979911 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20034336 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16467547 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16350151 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13899313 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12430048 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.11394749 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04749938 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.03756745 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03607441 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02325136 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01889883 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.00519873 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97516437 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.92141800 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90021763 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88523038 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 0.88102624 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87525484 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.85394922 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84423739 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78125958 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77620937 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76639549 |
| 56 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76470913 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75213119 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73948885 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73133056 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.72621709 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70211599 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.67093743 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65805750 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64733717 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64095263 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62673417 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62158519 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61956417 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61818560 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61207049 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60876659 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60582459 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.59856768 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58082756 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56165977 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55954936 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55484091 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.55012436 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54053277 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54032385 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53871974 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53670396 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53535127 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53286419 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51461461 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49975962 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49840263 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49540009 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.48837553 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48817684 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.48669812 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45698101 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44692011 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.40706604 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40638901 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39551933 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38050764 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36225755 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36112061 |
| 100 | RNA polymerase_Homo sapiens_hsa03020 | 0.35813679 |

